About the bill
- Full Title
A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes.
May 24, 2012 12:08 p.m.
Amendment Rejected 28/67May 24, 2012 12:37 p.m.
Amendment Rejected 46/50May 24, 2012 1:58 p.m.
Motion to Table Agreed to 78/15May 24, 2012 2:19 p.m.
Amendment Rejected 43/54May 24, 2012 2:38 p.m.
Amendment Rejected 9/88May 24, 2012 2:57 p.m.
Motion to Table Agreed to 77/20May 24, 2012 3:15 p.m.
Bill Passed 96/1Jun 25, 2012 5:31 p.m.
Cloture Motion Agreed to 89/3On the Motion (Motion to Concur in the House Amendment to Accompany S. 3187)
Jun 26, 2012 4:45 p.m.
Motion Agreed to 92/4
- Subject Areas
- Related Bills
Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.S. 2516 (Related)Food and Drug Administration Safety and Innovation Act
Reported by Committee
Last Action: May 7, 2012H.R. 5651 (Related)Food and Drug Administration Reform Act of 2012
Last Action: May 30, 2012
Search for similar bills.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2016). S. 3187 — 112th Congress: Food and Drug Administration Safety and Innovation Act. Retrieved from https://www.govtrack.us/congress/bills/112/s3187
“S. 3187 — 112th Congress: Food and Drug Administration Safety and Innovation Act.” www.GovTrack.us. 2012. April 30, 2016 <https://www.govtrack.us/congress/bills/112/s3187>
|title=S. 3187 (112th)
|accessdate=April 30, 2016
|author=112th Congress (2012)
|date=May 15, 2012
|quote=Food and Drug Administration Safety and Innovation Act